Tue, 21 Jan 2025, 12:07 am
Health

Studies show that the COVID-19 pill works against variants, Merck says

Merck’s experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of coronavirus, including the predominant and highly contagious delta, laboratory studies The company said on

read more

Side effects after booster dose similar to shot two: US study

Most side effects after a third dose of a Covid vaccine are mild or moderate, and occur at about as often as after shot two, a US study showed Tuesday

read more

WHO backs antibody treatment for high-risk Covid patients

The World Health Organization (WHO) on Friday recommended the synthetic antibody treatment Regeneron for Covid-19, but only in patients with specific health profiles. Persons with non-severe Covid-19 who are nonetheless

read more

‘Strong tobacco control is essential to achieve a tobacco-free Bangladesh’

Strict tobacco control is needed to protect public health and to achieve a tobacco-free Bangladesh by 2040, announced by the Prime Minister Sheikh Hasina, said experts. Therefore, it is necessary

read more

Pfizer says COVID-19 vaccine works in kids ages 5 to 11

Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek US authorization for this age group soon — a key step toward beginning

read more

Researchers Studying Cambodia bats to track origin of Covid-19

Researchers are collecting samples from bats in northern Cambodia in a bid to understand the coronavirus pandemic, returning to a region where a very similar virus was found in the

read more

‘Ebola is defeated’, says Congolese professor who discovered virus

Ebola has been defeated. Vaccines and medical treatments have brought the deadly and terrifying disease under control, says Jean-Jacques Muyembe, the Congolese professor who first discovered the virus more than

read more

6 months’ immunity in mild Covid patients as antibodies persist: Study

A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months. The findings of the

read more

Covid: Vaccine protection still strong – Oxford jab creator

The vaccines are still providing strong protection, a year on from the initial two doses, says the scientist who developed the Oxford-AZ vaccine. The UK’s vaccine advisory body is set

read more

Is there a link between post-Covid recovery and heart attacks?

These aren’t the only instances of people having encountered heart attacks post-COVID. An Oxford-led study conducted recently established that over 50%, or 5 out of every 10 COVID-19 patients with

read more

© All rights reserved © 2019 WeeklyBangladeshNY.Net
Theme Dwonload From ThemesBazar.Com